Bulk Manufacturer of Controlled Substances Application: Curia New York, Inc., 39646 [2024-10083]
Download as PDF
<![CDATA[
39646
Federal Register / Vol. 89, No. 91 / Thursday, May 9, 2024 / Notices
Cultural Affiliation
Based on the information available
and the results of consultation, cultural
affiliation is clearly identified by the
information available about the human
remains and associated funerary objects
described in this notice.
ddrumheller on DSK120RN23PROD with NOTICES1
Determinations
The California State University,
Sacramento has determined that:
• The human remains described in
this notice represent the physical
remains of nine individuals of Native
American ancestry.
• The 61,419 objects described in this
notice are reasonably believed to have
been placed intentionally with or near
individual human remains at the time of
death or later as part of the death rite
or ceremony.
• There is a reasonable connection
between the human remains and
associated funerary objects described in
this notice and the Berry Creek
Rancheria of Maidu Indians of
California; Enterprise Rancheria of
Maidu Indians of California; Greenville
Rancheria; Mechoopda Indian Tribe of
Chico Rancheria, California; and the
Mooretown Rancheria of Maidu Indians
of California.
Requests for Repatriation
Written requests for repatriation of the
human remains and associated funerary
objects in this notice must be sent to the
authorized representative identified in
this notice under ADDRESSES. Requests
for repatriation may be submitted by:
1. Any one or more of the Indian
Tribes or Native Hawaiian organizations
identified in this notice.
2. Any lineal descendant, Indian
Tribe, or Native Hawaiian organization
not identified in this notice who shows,
by a preponderance of the evidence, that
the requestor is a lineal descendant or
a culturally affiliated Indian Tribe or
Native Hawaiian organization.
Repatriation of the human remains
and associated funerary objects in this
notice to a requestor may occur on or
after June 10, 2024. If competing
requests for repatriation are received,
the California State University,
Sacramento must determine the most
appropriate requestor prior to
repatriation. Requests for joint
repatriation of the human remains and
associated funerary objects are
considered a single request and not
competing requests. The California State
University, Sacramento is responsible
for sending a copy of this notice to the
Indian Tribes and Native Hawaiian
organizations identified in this notice.
VerDate Sep<11>2014
17:17 May 08, 2024
Jkt 262001
Authority: Native American Graves
Protection and Repatriation Act, 25
U.S.C. 3003, and the implementing
regulations, 43 CFR 10.10.
ACTION:
Notice of application.
[FR Doc. 2024–10156 Filed 5–8–24; 8:45 am]
Curia New York, Inc. has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
BILLING CODE 4312–52–P
DATES:
Dated: April 30, 2024.
Melanie O’Brien,
Manager, National NAGPRA Program.
INTERNATIONAL TRADE
COMMISSION
[USITC SE–24–018]
Sunshine Act Meetings
United
States International Trade Commission.
TIME AND DATE: May 16, 2024 at 9:30
a.m.
PLACE: Room 101, 500 E Street SW,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: none.
2. Minutes.
3. Ratification List.
4. Commission vote on Inv. Nos. 701–
TA–689 and 731–TA–1618 (Final) (NonRefillable Steel Cylinders from India.
The Commission currently is scheduled
to complete and file its determination
and views on May 28, 2024.
5. Outstanding action jackets: none.
CONTACT PERSON FOR MORE INFORMATION:
Sharon Bellamy, Supervisory Hearings
and Information Officer, 202–205–2000.
The Commission is holding the
meeting under the Government in the
Sunshine Act, 5 U.S.C. 552(b). In
accordance with Commission policy,
subject matter listed above, not disposed
of at the scheduled meeting, may be
carried over to the agenda of the
following meeting.
AGENCY HOLDING THE MEETING:
By order of the Commission.
Issued: May 7, 2024.
Sharon Bellamy,
Supervisory Hearings and Information
Officer.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 8, 2024. Such persons
may also file a written request for a
hearing on the application on or before
July 8, 2024.
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on April 12, 2024, Curia
New York, Inc., 33 Riverside Avenue,
Rensselaer, New York 12144–2951,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Gamma Hydroxybutyric Acid ..
[FR Doc. 2024–10261 Filed 5–7–24; 4:15 pm]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1366]
Drug
code
Controlled substance
I
2010
Schedule
I
I
The company plans to manufacture
the above controlled substances as bulk
active pharmaceutical ingredients for
use in product development and for
distribution to its customers. No other
activities for these drug codes are
authorized for this registration.
Bulk Manufacturer of Controlled
Substances Application: Curia New
York, Inc.
Marsha Ikner,
Acting Deputy Assistant Administrator.
Drug Enforcement
Administration, Justice.
BILLING CODE P
AGENCY:
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
[FR Doc. 2024–10083 Filed 5–8–24; 8:45 am]
E:\FR\FM\09MYN1.SGM
09MYN1
]]>Agencies
[Federal Register Volume 89, Number 91 (Thursday, May 9, 2024)]
[Notices]
[Page 39646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-10083]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1366]
Bulk Manufacturer of Controlled Substances Application: Curia New
York, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Curia New York, Inc. has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
July 8, 2024. Such persons may also file a written request for a
hearing on the application on or before July 8, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on April 12, 2024, Curia New York, Inc., 33 Riverside
Avenue, Rensselaer, New York 12144-2951, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............. 2010 I
------------------------------------------------------------------------
The company plans to manufacture the above controlled substances as
bulk active pharmaceutical ingredients for use in product development
and for distribution to its customers. No other activities for these
drug codes are authorized for this registration.
Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-10083 Filed 5-8-24; 8:45 am]
BILLING CODE P
